Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

South32 share price (ASX:S32) rebounds 2% after Monday drop, with results day looming

South32 share price (ASX:S32) rebounds 2% after Monday drop, with results day looming

South32 shares closed up 2.0% at A$4.51 in Sydney, rebounding from a 4.3% drop the previous day. The move comes ahead of the miner’s half-year results and interim dividend announcement set for Feb. 12. The Reserve Bank of Australia raised rates to 3.85%, lifting the Australian dollar above 70 U.S. cents. Silver prices remain volatile after a record high and steep drop last week.
3 February 2026
·
Lynas Rare Earths share price jumps after Trump’s Project Vault shakes up rare earth supply talk

Lynas Rare Earths share price jumps after Trump’s Project Vault shakes up rare earth supply talk

Lynas Rare Earths shares rose 3.3% to A$15.25 Tuesday after Trump’s “Project Vault” mineral reserve plan and ahead of further White House comments. The stock rebounded from last week’s drop, when reports of a U.S. retreat from price floor talks triggered sharp losses across the sector. Japan recovered rare-earth-rich seabed mud, while TDK warned of Chinese export limits disrupting supplies. Lynas quarterly revenue rose to A$201.9 million despite lower output.
3 February 2026
··
Thames Water’s £16bn rescue deal is close — lenders may take 30% losses

Thames Water’s £16bn rescue deal is close — lenders may take 30% losses

Creditors are nearing a £16 billion rescue deal for Thames Water, with senior lenders facing losses of up to 30% on Class A debt, according to reports. The plan would give creditors at least a 10% equity stake in the recapitalised utility. A creditor group holding £13 billion of debt aims to reach terms with Ofwat by mid-February. Thames Water serves 16 million customers and has faced over £100 million in fines for sewage spills.
3 February 2026
Xero share price jumps on AI push and fresh US payments numbers — here’s what investors watch next

Xero share price jumps on AI push and fresh US payments numbers — here’s what investors watch next

Xero shares rose 2.6% to A$96.10 after an investor briefing outlined AI and U.S. payments plans. The company expects Melio to reach adjusted-EBITDA breakeven by H2 FY28. BillPay payments revenue jumped 74% to NZ$158 million in FY25, while U.S. gross margin slipped to 38%. Xero will update its guidance framework with full-year results on May 14.
3 February 2026
···
1 … 40 41 42 43 44 … 535

Stock Market Today

TSMC stock price jumps as chip rally returns — what to watch before Feb. 10 sales update

7 February 2026
TAIPEI, Feb 7, 2026, 23:19 (GMT+8) — Market closed. Taiwan Semiconductor Manufacturing Co’s U.S.-listed American depositary receipts (TSM) jumped 5.5% on Friday to $348.85, after trading between $330.15 and $350.81. In Taipei, the stock (2330.TW) closed up 0.85% at NT$1,780, its high for the day, with about 35 million shares changing hands. (Investing.com) The bounce matters because the AI trade has been wobbling, and money has started to move away from software and back into the hardware that runs large models. Semiconductor stocks are up about 65% since early 2025, while software and services shares are down 8%, a Reuters
Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Go toTop